Compared with other H3R antagonists, CPX exhibited a non-interactive antagonistic action with other histamine receptors and blockade of H3R by CPX showed protection in a series of pathologic conditions, such as schizophrenia, Alzheimer's disease and sleep disorders [27–29]. This evidence concerns the gene HRH3 and sleep disorder.